Physician profile
Brian Lai
NPI 1700176971
$1,340.70
in general payments reported to CMS, 2019-2025
13 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $39.31 · 2021: $130 · 2023: $41.02 · 2024: $68.03 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $437.87 | 2019-2025 | Eterna |
| Saluda Medical Americas, INC. | $348.79 | 2025 | Evoke |
| Nevro Corp. | $140.05 | 2019 | |
| Grt US Holding, INC. | $130.00 | 2021 | |
| Vertiflex, INC. | $126.29 | 2019 | |
| Biotronik Nro, INC. | $30.81 | 2024 | Prospera |
| Team_makena_llc | $28.98 | 2019 | |
| Daiichi Sankyo INC. | $21.51 | 2023 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $19.50 | 2019 | |
| Boston Scientific Corporation | $17.96 | 2020 | |
| Scilex Pharmaceuticals INC. | $16.11 | 2019 | |
| Biodelivery Sciences International, INC. | $13.45 | 2019 | |
| Mml US, INC. | $9.38 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.